Francesca Conti

489 total citations
19 papers, 343 citations indexed

About

Francesca Conti is a scholar working on Oncology, Cancer Research and Dermatology. According to data from OpenAlex, Francesca Conti has authored 19 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Cancer Research and 2 papers in Dermatology. Recurrent topics in Francesca Conti's work include Cancer Treatment and Pharmacology (15 papers), Breast Cancer Treatment Studies (11 papers) and Neutropenia and Cancer Infections (5 papers). Francesca Conti is often cited by papers focused on Cancer Treatment and Pharmacology (15 papers), Breast Cancer Treatment Studies (11 papers) and Neutropenia and Cancer Infections (5 papers). Francesca Conti collaborates with scholars based in United States, Italy and Malaysia. Francesca Conti's co-authors include Patrizia Vici, Luigi Di Lauro, Massimo Lopez, Claudio Botti, Diana Giannarelli, Alessandra Fabi, Paolo Carlini, Serena Di Cosimo, Cecilia Nisticò and Paola Papaldo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Aquaculture.

In The Last Decade

Francesca Conti

17 papers receiving 334 citations

Peers

Francesca Conti

ONCOL

GENET

PRM

Paolo Marolla Italy

Silvia Bolzonello Italy

Pauline K. Park United States

Erica Quaquarini Italy

Erin Powell Canada

Krista Menard United States

J. P. Eder United States

J Reichrath Germany

Yi‐Fang Tsai Taiwan

Fergus Keane United States

Paolo Marolla Italy

Francesca Conti

170 ×0.7

ONCOL

70 ×0.5

77 ×0.9

45 ×1.0

GENET

24 ×0.6

PRM

Citations per year, relative to Francesca Conti Francesca Conti (= 1×) peers Paolo Marolla

Countries citing papers authored by Francesca Conti

Since Specialization

Citations

This map shows the geographic impact of Francesca Conti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Conti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Conti more than expected).

Fields of papers citing papers by Francesca Conti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Conti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Conti. The network helps show where Francesca Conti may publish in the future.

Co-authorship network of co-authors of Francesca Conti

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Conti. A scholar is included among the top collaborators of Francesca Conti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Conti. Francesca Conti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Rossi, Lorenzo, Carlo Bibbiani, Francesca Conti, et al.. (2025). Growth performances of gilthead seabream (Sparus aurata) fed alternative diets for “circular” land-based IMTA production. Aquaculture. 609. 742789–742789.

Mortellaro, Alessandra, Matteo Zoccolillo, Immacolata Brigida, et al.. (2021). Lentiviral-Mediated Gene Therapy for the Treatment of Adenosine Deaminase 2 Deficiency. Blood. 138(Supplement 1). 2937–2937.

Vici, Patrizia, Laura Pizzuti, Teresa Gamucci, et al.. (2014). Non-Pegylated Liposomal Doxorubicin-Cyclophosphamide in Sequential Regimens with Taxanes as Neoadjuvant Chemotherapy in Breast Cancer Patients. Journal of Cancer. 5(6). 398–405. 6 indexed citations

Vici, Patrizia, Laura Pizzuti, Clara Natoli, et al.. (2014). Triple positive breast cancer: A distinct subtype?. Cancer Treatment Reviews. 41(2). 69–76. 86 indexed citations

Vici, Patrizia, Alessandra Fabi, Giulio Metro, et al.. (2010). Phase I–II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines. Cancer Chemotherapy and Pharmacology. 67(3). 687–693. 7 indexed citations

López, Manuela G., Luigi Di Lauro, Paolo Foggi, et al.. (2009). [Adjuvant chemotherapy in hormone-receptor positive HER2-negative early breast cancer].. PubMed. 160(6). 481–8. 2 indexed citations

Lauro, Luigi Di, et al.. (2009). [Target selectivity of anticancer drugs].. PubMed. 159(3). 189–206. 2 indexed citations

Sergi, Domenico, et al.. (2008). [Neoadjuvant endocrine therapy for locally advanced breast cancer].. PubMed. 158(5). 441–52. 1 indexed citations

Conti, Francesca, et al.. (2007). [New combination chemotherapy regimens in the primary treatment of operable breast cancer].. PubMed. 158(1). 55–75. 3 indexed citations

10.

Conti, Francesca, Silvia Carpano, Domenico Sergi, et al.. (2007). [High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].. PubMed. 158(4). 331–41. 2 indexed citations

11.

Vici, Patrizia, Paolo Foggi, Silvia Carpano, et al.. (2006). High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients.. PubMed. 25(1). 39–44. 9 indexed citations

12.

Papaldo, Paola, Massimo Lopez, Paolo Marolla, et al.. (2005). Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide. Journal of Clinical Oncology. 23(28). 6908–6918. 74 indexed citations

13.

Papaldo, Paola, Massimo Lopez, Enrico Cortesi, et al.. (2003). Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide. Journal of Clinical Oncology. 21(18). 3462–3468. 65 indexed citations

14.

Vici, Patrizia, Giuseppe Colucci, Vittorio Gebbia, et al.. (2002). First-Line Treatment With Epirubicin and Vinorelbine in Metastatic Breast Cancer. Journal of Clinical Oncology. 20(11). 2689–2694. 33 indexed citations

15.

Vici, Patrizia, et al.. (2000). First-Line Chemotherapy with Vinorelbine and Paclitaxel as Simultaneous Infusion in Advanced Breast Cancer. Oncology. 58(1). 3–7. 14 indexed citations

16.

Vici, Patrizia, Luigi Di Lauro, Antonella Amodio, et al.. (2000). Docetaxel in Patients with Anthracycline-Resistant Advanced Breast Cancer. Oncology. 60(1). 60–65. 17 indexed citations

17.

Vici, Patrizia, et al.. (1999). [Simultaneous infusion of vinorelbin and taxol as first-line chemotherapy in metastasized breast cancer].. PubMed. 149(4). 255–9. 1 indexed citations

18.

Vici, Patrizia, et al.. (1997). Paclitaxel Activity in Anthracycline Refractory Breast Cancer Patients. Tumori Journal. 83(3). 661–664. 9 indexed citations

19.

López, M, Patrizia Vici, Luigi Di Lauro, et al.. (1995). Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer. European Journal of Cancer. 31(10). 1611–1614. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact